We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VVOS market cap is 22.48M. The company's latest EPS is USD -2.8091 and P/E is -1.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.3M | 3.25M | 3.42M | 4.05M | 3.86M |
| Operating Income | -3.49M | -4.28M | -3.79M | -1.93M | -2.65M |
| Net Income | -2.09M | -4.26M | -3.76M | -1.93M | -2.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.39M | 13.07M | 16.89M | 16.02M | 13.8M |
| Operating Income | -10.58M | -12.04M | -19.47M | -25.03M | -17.3M |
| Net Income | -11.75M | -6.13M | -20.29M | -23.85M | -13.58M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.32M | 10.73M | 11.8M | 15.84M | 15.35M |
| Total Liabilities | 10.27M | 10.32M | 11.22M | 9.5M | 7.68M |
| Total Equity | 46k | 411k | 582k | 6.35M | 7.67M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.55M | 25.33M | 33.69M | 13.72M | 10.73M |
| Total Liabilities | 9.18M | 8.41M | 8.15M | 8.92M | 10.32M |
| Total Equity | -2.94M | 16.92M | 25.54M | 4.8M | 411k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.2M | -11.95M | -2.52M | -5.56M | -9.75M |
| Investing | -688k | -853k | -151k | -211k | -403k |
| Financing | 7.36M | 10.92M | 3.64M | 11.04M | 14.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.34M | -5.68M | -15.74M | -19.59M | -11.95M |
| Investing | 86k | -120k | -2.61M | -924k | -853k |
| Financing | 4.47M | 23.54M | 24.17M | N/A | 10.92M |
| Market Cap | 22.48M |
| Price to Earnings Ratio | -1.66 |
| Price to Sales Ratio | 1.63 |
| Price to Cash Ratio | 13.68 |
| Price to Book Ratio | 54.71 |
| Dividend Yield | - |
| Shares Outstanding | 4.84M |
| Average Volume (1 week) | 322.87k |
| Average Volume (1 Month) | 241.45k |
| 52 Week Change | -58.30% |
| 52 Week High | 12.8308 |
| 52 Week Low | 1.91 |
| Spread (Intraday) | 0.44 (8.82%) |
| Company Name | Vivos Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://vivos.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
